| |
1. High prevalence of glucokinase
mutations in Italian children with MODY. Influence
on glucose tolerance, first-phase insulin response,
insulin sensitivity and BMI; O.Massa, F. Barbetti
et al; Diabetologia (2001)44: 898-905
2. Molecular Mechanisms and Clinical Pathophysiology
of Maturity Onset Diabetes of the Young; S. Fajans;
N. Engl. J. Med. vol 345, N°13, sept 2001,
971-979
3. A high prevalence of glucokinase mutations in
gestational diabetic subjects selected by clinical
criteria; S. Ellard et al, Diabetologia (2000)
43: 250-253
4. Glucokinase (GCK) Mutation in Hyper- and Hypoglycemia:
Maturity Onset Diabetes of the Young, Permanent
Neonatal Diabetes, and Hyperinsulinemia of Infancy;
Gloyn A. Human Mutation 22:353-362 (2003)
5. Identification of 21 Novel Glucokinase (GCK)
Mutation in UK and European Caucasians with Maturity
Onset Diabetes of the Young (MODY); K. L. Thomson
et al, Human Mutation mutation in brief #657 (2003)
Online
6. Genetic and metabolic heterogeneity of maturity-onset
diabetes of the young; P. Froguel, M. Vaxillaire,
G. Velho; Diabetes Reviews, volume5, number 2,
1997
7. Maturity Onset Diabetes of the Young: Clinical
Heterogeneity Explained by Genetic Heterogeneity;
A.T. Hattersley et al; Diabetic Medicine, 1998;
15: 15-24
8. Maturity Onset Diabetes of the Young MODY: genetic
and clinical characteristics; Velho et al; Horm
Res, 2002; 57 (suppl 1) 29-33
9. Glucokinase mutations associated with non-insulin-dependent
(type2) diabetes mellitus have decreased enzymatic
activity: implication for structure/function relationships;
M Gidh et al; Proc. Natl. Acad. Sci. USA, Vol 90,
pp 1932-1936, March 1993Biochemistry
10. Human glucokinase gene: isolation, characterization,
and identification of two missense mutations linked
to early-onset non-insulin-dependent (type 2) diabetes
mellitus; M. Stoffel et al;Procl.. Natl. Acad.
Sci. USA,vol 89, pp 7698-7702,August 1992 Genetics
11. Ricerca sul diabete mellito ad elevata familiarità (AMD)]
12. The genetic abnormality in the beta cell determines
the response to an oral glucose load; Stride A.,
Barbetti F. et al; Diabetologia (2002) 45: 427-435
13. Chronic diabetic complications in patients
with MODY 3 diabetes; B. Isomaa et al, Diabetologia
(1998) 41: 467-473
14. Characterization of the MODY 3 Phenotype, Early-Onset
Diabetes Caused by an Insulin Secretion Defect;
M. Lehto et al, J. Clin. Invest. Volume 99, number
4, February 1997, 582-591
15. High frequency of mutations in the HNF- 1a
gene (TCF1) in non-obese patients with diabetes
of youth in Japanese and identification of a case
of digenic inheritance; N. Tonooka et al, Diabetologia
(2002)45: 1709-1712
16. Hepatocyte Nuclear Factor 1 Alpha (HNF-1a)
Mutation in Maturity-Onset Diabetes of the Young;
S. Ellard, Human Mutation 16:377-385 (2000)
17. Diabetes complications in NIDDM Kindres linked
to the MODY3 Locus on Chromosome 12q; G. Vhelo
et al, Diabetes Care, volume 19, number9, september
1996
18. Identification of eight novel glucokinase mutations
in Italian Children with Maturity-Onset Diabetes
of the Young; Mantovani, V. Human Mutation mutatation
in brief #650 (2003) On lin
|
